Moderate to Severe Atopic Dermatitis: The Role and Clinical Utility of Targeted Therapy

Co-Chairs, Jonathan I. Silverberg, MD, PhD, MPH, and Linda Stein Gold, MD, discuss atopic dermatitis in this CME/CE/AAPA activity titled “Bridging the Gap to Increased Patient Satisfaction in Moderate to Severe Atopic Dermatitis: Understanding the Role and Clinical Utility of Targeted Therapy.” For the full presentation, downloadable Practice Aids, slides, and complete CME/CE/AAPA information, and to apply for credit, please visit us at PeerView.com/DRZ865. CME/CE/AAPA credit will be available until October 17, 2024.